Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Harrison

Showing results (941-950 of 972) with videos related to

Pageof 98
Sort By:
Nature Medicine|January 24, 2019
Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.
Genetics|July 7, 2017
Tracing Genetic Exchange and Biogeography of <i>Cryptococcus neoformans</i> var. <i>grubii</i> at the Global Population LevelJohanna Rhodes, Christopher A Desjardins, Sean M Sykes, et al.
Trials|March 25, 2026
Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trialKyla Murphy, Jeremy S Nel, Mahomed-Yunus Moosa, et al.
The Lancet. Global Health|April 27, 2025
Personalised risk-prediction tools for cryptococcal meningitis mortality to guide treatment stratification in sub-Saharan Africa: a prognostic modelling study based on pooled analysis of two randomised controlled trialsThomas H A Samuels, Sile F Molloy, David S Lawrence, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 21, 2017
A prospective study of maternal, fetal and neonatal outcomes in the setting of cesarean section in low- and middle-income countriesMargo S Harrison, Omrana Pasha, Sarah Saleem, et al.
Trials|January 16, 2019
Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority TrialDavid S Lawrence, Nabila Youssouf, Síle F Molloy, et al.
Trials|November 25, 2018
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority TrialDavid S Lawrence, Nabila Youssouf, Síle F Molloy, et al.
Journal of Neurosurgery. Spine|September 6, 2024
Does comorbid depression and anxiety portend poor long-term outcomes following surgery for lumbar spondylolisthesis? Five-year analysis of the Quality Outcomes DatabaseJoseph DiDomenico, S Harrison Farber, Michael S Virk, et al.
Cell|June 4, 2016
Dual RING E3 Architectures Regulate Multiubiquitination and Ubiquitin Chain Elongation by APC/CNicholas G Brown, Ryan VanderLinden, Edmond R Watson, et al.
Critical Care Medicine|March 15, 2024
A Modified Delphi Consensus Approach to Define Entrustable Professional Activities for Neurocritical Care Advanced Practice ProvidersDaniel S Harrison, Erika J Sigman, Judy H Ch'ang, et al.
Pageof 98

Showing results (941-950 of 972) with videos related to

Sort By:
Pageof 98
Nature Medicine|January 24, 2019
Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.
Genetics|July 7, 2017
Tracing Genetic Exchange and Biogeography of <i>Cryptococcus neoformans</i> var. <i>grubii</i> at the Global Population LevelJohanna Rhodes, Christopher A Desjardins, Sean M Sykes, et al.
Trials|March 25, 2026
Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trialKyla Murphy, Jeremy S Nel, Mahomed-Yunus Moosa, et al.
The Lancet. Global Health|April 27, 2025
Personalised risk-prediction tools for cryptococcal meningitis mortality to guide treatment stratification in sub-Saharan Africa: a prognostic modelling study based on pooled analysis of two randomised controlled trialsThomas H A Samuels, Sile F Molloy, David S Lawrence, et al.
Acta Obstetricia Et Gynecologica Scandinavica|January 21, 2017
A prospective study of maternal, fetal and neonatal outcomes in the setting of cesarean section in low- and middle-income countriesMargo S Harrison, Omrana Pasha, Sarah Saleem, et al.
Trials|January 16, 2019
Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority TrialDavid S Lawrence, Nabila Youssouf, Síle F Molloy, et al.
Trials|November 25, 2018
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority TrialDavid S Lawrence, Nabila Youssouf, Síle F Molloy, et al.
Journal of Neurosurgery. Spine|September 6, 2024
Does comorbid depression and anxiety portend poor long-term outcomes following surgery for lumbar spondylolisthesis? Five-year analysis of the Quality Outcomes DatabaseJoseph DiDomenico, S Harrison Farber, Michael S Virk, et al.
Cell|June 4, 2016
Dual RING E3 Architectures Regulate Multiubiquitination and Ubiquitin Chain Elongation by APC/CNicholas G Brown, Ryan VanderLinden, Edmond R Watson, et al.
Critical Care Medicine|March 15, 2024
A Modified Delphi Consensus Approach to Define Entrustable Professional Activities for Neurocritical Care Advanced Practice ProvidersDaniel S Harrison, Erika J Sigman, Judy H Ch'ang, et al.
Pageof 98